Silo Pharma (SILO) Loans - Gross (2022 - 2023)
Silo Pharma (SILO) posted Loans - Gross of $69600.0 for Q4 2023, up 5.44% sequentially from $66010.0 in Q4 2022, and up 5.44% YoY from $66010.0 in Q4 2022.
Silo Pharma (SILO) Loans - Gross (2022 - 2023) Analysis & Trends
Silo Pharma has reported Loans - Gross for 2 years, with the latest figure at $69600.0 in Q4 2023.
- Quarterly Loans - Gross rose 5.44% year-over-year to $69600.0 in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $69600.0 (up 5.44% YoY) and the FY2023 annual result came in at $69600.0, up 5.44% from the prior year.
- Loans - Gross rose to $69600.0 in Q4 2023 per SILO's latest filing, from $66010.0 in the prior quarter.
- Over five years, Loans - Gross peaked at $69600.0 in Q4 2023 and troughed at $66010.0 in Q4 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Loans - Gross (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.72 Bn | 77.73 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.93 Bn | 59.75 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.97 Bn | 36.87 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.22 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.98 Bn | 9.59 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | - |
| 10 | Silo Pharma | 2.96 Mn | 2.96 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 69,600.00 |
| Dec 31, 2022 | 66,010.00 |